Literature DB >> 24200271

Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China.

H-Q Pan1, S Bele, Y Feng, S-S Qiu, J-Q Lü, S-W Tang, H-B Shen, J-M Wang, L-M Zhu.   

Abstract

SETTING: A county in Jiangsu Province, China.
OBJECTIVES: To estimate the costs of the diagnosis and treatment of tuberculosis (TB) from the patient's perspective and to identify determinants of the patient's financial burden.
DESIGN: In a cross-sectional survey, we interviewed 316 patients diagnosed from January 2010 to May 2011 who had already completed their anti-tuberculosis treatment. The financial burden on TB patients included out-of-pocket costs and productivity losses.
RESULTS: The average per capita total out-of-pocket cost was 3024.0 Chinese yuan (CNY), with a median cost of 1086 CNY (interquartile range [IQR] 480-2456). Mean out-of-pocket medical and non-medical costs were respectively 2565.7 CNY and 458.3 CNY. Productivity lost by patients and family members was 2615.2 CNY (median 500, IQR 250-2025). Factors associated with out-of-pocket costs and productivity losses included hospitalisation, adverse drug reactions, cost of drugs to 'protect' the liver, cost of second-line anti-tuberculosis drugs and diagnostic delay.
CONCLUSION: Although the government of China has implemented a 'free TB service policy', the economic burden on patients is still heavy. More patient-centred interventions are essential to reduce the financial burden on patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24200271     DOI: 10.5588/ijtld.13.0144

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  25 in total

1.  Delays and Pathways to Final Tuberculosis Diagnosis in Patients from a Referral Hospital in Urban China.

Authors:  Leonardo Martinez; Lin Xu; Cheng Chen; Juliet N Sekandi; Yongzhong Zhu; Changsheng Zhang; Christopher C Whalen; Limei Zhu
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

2.  Is tuberculosis treatment really free in China? A study comparing two areas with different management models.

Authors:  Sangsang Qiu; Hongqiu Pan; Simin Zhang; Xianzhen Peng; Xianzhi Zheng; Guisheng Xu; Min Wang; Jianming Wang; Hui Lu
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 3.  Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Authors:  Yoko V Laurence; Ulla K Griffiths; Anna Vassall
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

4.  Are free anti-tuberculosis drugs enough? An empirical study from three cities in China.

Authors:  Shanquan Chen; Hui Zhang; Yao Pan; Qian Long; Li Xiang; Lan Yao; Henry Lucas
Journal:  Infect Dis Poverty       Date:  2015-10-28       Impact factor: 4.520

5.  Spatial-Temporal Epidemiology of Tuberculosis in Mainland China: An Analysis Based on Bayesian Theory.

Authors:  Kai Cao; Kun Yang; Chao Wang; Jin Guo; Lixin Tao; Qingrong Liu; Mahara Gehendra; Yingjie Zhang; Xiuhua Guo
Journal:  Int J Environ Res Public Health       Date:  2016-05-05       Impact factor: 3.390

6.  Factors that associated with TB patient admission rate and TB inpatient service cost: a cross-sectional study in China.

Authors:  Hongyan Hu; Jiaying Chen; Kaori D Sato; Yang Zhou; Hui Jiang; Pingbo Wu; Hong Wang
Journal:  Infect Dis Poverty       Date:  2016-01-20       Impact factor: 4.520

7.  Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study.

Authors:  Leonardo Martinez; Limei Zhu; Maria E Castellanos; Qiao Liu; Cheng Chen; Benjamin D Hallowell; Christopher C Whalen
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

8.  Population aging and migrant workers: bottlenecks in tuberculosis control in rural China.

Authors:  Sumedh Bele; Wei Jiang; Hui Lu; Hua You; Hong Fan; Lifang Huang; Qungang Wang; Hongbing Shen; Jianming Wang
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  Implementing a "free" tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world.

Authors:  Xinxin Jia; Jiaying Chen; Siyuan Zhang; Bing Dai; Qian Long; Shenglan Tang
Journal:  Infect Dis Poverty       Date:  2016-01-22       Impact factor: 4.520

10.  The impact of the new cooperative medical scheme on financial burden of tuberculosis patients: evidence from six counties in China.

Authors:  Li Xiang; Yao Pan; Shuangyi Hou; Hongwei Zhang; Kaori D Sato; Qiang Li; Jing Wang; Shenglan Tang
Journal:  Infect Dis Poverty       Date:  2016-01-28       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.